Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?

Autoimmunity Reviews

Volumn 14, Issue 9, 2015, Pages 760-762

  De Carolis, S ^a   Botta, A ^a   Salvi, S ^a   di Pasquo, E ^a   Del Sordo, G ^a   Garufi, C ^a   Lanzone, A ^a   De Carolis, M P ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FOLIC ACID; HYDROXYCHLOROQUINE; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; PROPRANOLOL; RAMIPRIL; VITAMIN D;

ADD ON THERAPY; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; CASE REPORT; CESAREAN SECTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HELLP SYNDROME; HUMAN; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; OLIGOHYDRAMNIOS; PATIENT COUNSELING; PREGNANCY DISORDER; PREGNANCY OUTCOME; PRENATAL CARE; REFRACTORY OBSTETRICAL ANTIPHOSPHOLIPID SYNDROME; REVIEW; STEROID THERAPY; IMMUNOLOGY; PHENOTYPE; PREGNANCY; PREGNANCY COMPLICATION;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; HYDROXYCHLOROQUINE; PHENOTYPE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 84938207306     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2015.04.010     Document Type: Review

References (15)

1. Mekinian A., Costedoat-Chalumeau N., Masseau A., Tincani A., De Carolis S., Alijotas-Reig J., et al. Obstetrical APS: is there a place for hydroxychloroquine to improve the pregnancy outcome?. Autoimmun Rev 2015, 14:23-29.
2. Mekinian A., Lazzaroni M.G., Kuzenko A., Alijotas-Reig J., Ruffatti A., Levy P., et al. The efficacy of hydroxychloroquine for obstetrical outcome in antiphospholipid syndrome: data from a European multi center retrospective study. Autoimmun Rev 2015, 40:498-502.
3. Broder A., Putterman C. Hydroxychloroquine use is associated with lower odds of persistently positive antiphospholipid antibodies and/or lupus anticoagulant in systemic lupus erythematosus. J Rheumatol Jan 2013, 40:30-33.
4. Chrisman O.D., Snook G.A., Wilson T.C., Short J.Y. Prevention of venous thromboembolism by administration of hydroxychloroquine. A preliminary report. J Bone Joint Surg Am 1976, 58(7):918-920.
5. Schmidt-Tanguy A., Voswinkel J., Henrion D., Subra J., Loufrani L., Rohmer V., et al. Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients. J Thromb Haemost 2013, 11(10):1927-1929.
6. Wu X.X., Guller S., Rand J.H. Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression. Am J Obstet Gynecol 2011, 205(6):576-577. [514].
7. Albert C.R., Schlesinger W.J., Viall C.A., Mulla M.J., Brosens J.J., Chamley L.W., et al. Effect of hydroxychloroquine on antiphospholipid antibody-induced changes in first trimester trophoblast function. Am J Reprod Immunol 2014, 71(2):154-164.
8. Marchetti T., Ruffatti A., Wuillemin C., deMoerloose P., Cohen M. Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies. J Thromb Haemost 2014, 12(6):910-920.
9. Jang C.H., Choi J.H., Byun M.S., Jue D.M. Chloroquine inhibits production of TNF-alpha, IL-1 beta, and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes. Rheumatology 2006, 45:703-710.
10. Ruffatti A., Tonello M., Cavazzana A., Bagatella P., Pengo V. Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy. Thromb Res 2009, 123:482-487.
11. Hernandez-Molina G., Espericueta-Arriola G., Cabral A.R. The role of lupus anticoagulant and triple marker positivity as risk factors for rethrombosis in patients with primary antiphospholipid syndrome. Clin Exp Rheumatol 2013, 31:382-388.
12. Ruffatti A., Tonello M., Visentin M.S., et al. Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multi-center case-control study. Rheumatology 2011, 50:1684-1689.
13. Lockshin M.D., Kim M., Laskin C.A., et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibodies, in patients with antiphospholipid antibodies. Arthritis Rheum 2012, 64:2311-2318.
14. Simchen M.J., Dulitzki M., Rofe G., Shani H., Langevitz P., Shiff E., et al. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome. Acta Obstet Gynecol Scand 2011, 90:1428-1433.
15. Abou-Nassar K., Carrier M., Ramsay T., Rodger M.A. The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis. Thromb Res 2011, 128:77-85.